If you experience any unexpected symptoms after administration including nausea, vomiting, injection site swelling or redness, signs of allergic reaction (rash, difficulty breathing, swelling of the face or throat), or systemic symptoms such as fever you should: Contact your GP promptly for non-urgent concerns Call NHS 111 if you are unsure whether your symptoms require urgent attention Call 999 or attend A&E immediately if you experience a severe allergic reaction, chest pain, difficulty breathing, or loss of consciousness Suspected side effects or adverse reactions to any medicine, including investigational products, should be reported to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk
As concomitant abuse of different drugs is common in todays society, the effects of GLP-1R agonists on the intake on multiple addictive drugs in a situation where the rats can choose between different drugs should be tested
however, during allergic condition, VIP effects can be attenuated by released inflammatory mediators that result in AHR [83]
[1] A secondary and post-hoc analysis of the same trial also reported clinically relevant reductions in blood pressure
